Minerdi D, Sadeghi S, Pautasso L, Morra S, Aigotti R, Medana C, et al. Expression and role of CYP505A1 in pathogenicity of Fusarium oxysporum f. sp. lactucae. Biochim Biophys Acta Proteins Proteom. 2020;1868:140268 pubmed publisher

Froeling F, Swamynathan M, Deschênes A, Chio I, Brosnan E, Yao M, et al. Bioactivation of Napabucasin Triggers Reactive Oxygen Species-Mediated Cancer Cell Death. Clin Cancer Res. 2019;25:7162-7174 pubmed publisher

Sun X, Wu C, Qiu Y, Wu Y, Chen J, Huang J, et al. Heme oxygenase-1 attenuates seawater drowning-induced acute lung injury through a reduction in inflammation and oxidative stress. Int Immunopharmacol. 2019;74:105634 pubmed publisher

Kadowaki T, Yukitake H, Naito M, Sato K, Kikuchi Y, Kondo Y, et al. A two-component system regulates gene expression of the type IX secretion component proteins via an ECF sigma factor. Sci Rep. 2016;6:23288 pubmed publisher

Meints C, Parke S, Wolthers K. Proximal FAD histidine residue influences interflavin electron transfer in cytochrome P450 reductase and methionine synthase reductase. Arch Biochem Biophys. 2014;547:18-26 pubmed publisher

Sugishima M, Sato H, Higashimoto Y, Harada J, Wada K, Fukuyama K, et al. Structural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenase. Proc Natl Acad Sci U S A. 2014;111:2524-9 pubmed publisher

Cankar K, van Houwelingen A, Goedbloed M, Renirie R, de Jong R, Bouwmeester H, et al. Valencene oxidase CYP706M1 from Alaska cedar (Callitropsis nootkatensis). FEBS Lett. 2014;588:1001-7 pubmed publisher

Stiborova M, Moserova M, Cerná V, Indra R, Dracinsky M, Sulc M, et al. Cytochrome b5 and epoxide hydrolase contribute to benzo[a]pyrene-DNA adduct formation catalyzed by cytochrome P450 1A1 under low NADPH:P450 oxidoreductase conditions. Toxicology. 2014;318:1-12 pubmed publisher

Oguro A, Koyama C, Xu J, Imaoka S. A cellular stress response (CSR) that interacts with NADPH-P450 reductase (NPR) is a new regulator of hypoxic response. Biochem Biophys Res Commun. 2014;445:43-7 pubmed publisher

Simtchouk S, Eng J, Meints C, Makins C, Wolthers K. Kinetic analysis of cytochrome P450 reductase from Artemisia annua reveals accelerated rates of NADH-dependent flavin reduction. FEBS J. 2013;280:6627-42 pubmed publisher

Su J, Gu Y, Pruijn F, Smaill J, Patterson A, Guise C, et al. Zinc finger nuclease knock-out of NADPH:cytochrome P450 oxidoreductase (POR) in human tumor cell lines demonstrates that hypoxia-activated prodrugs differ in POR dependence. J Biol Chem. 2013;288:37138-53 pubmed publisher

Zhu Y, Ding X, Fang C, Zhang Q. Regulation of intestinal cytochrome P450 expression by hepatic cytochrome P450: possible involvement of fibroblast growth factor 15 and impact on systemic drug exposure. Mol Pharmacol. 2014;85:139-47 pubmed publisher

Weightman P, Smith C, Convery J, Harrison P, Khara B, Scrutton N. Conformational change induced by electron transfer in a monolayer of cytochrome P450 reductase adsorbed at the Au(110)-phosphate buffer interface. Phys Rev E Stat Nonlin Soft Matter Phys. 2013;88:032715 pubmed

Elens L, Sombogaard F, Hesselink D, van Schaik R, van Gelder T. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus. Pharmacogenet Genomics. 2013;23:649-57 pubmed publisher

Tran N, Nguyen D, Dwaraknath S, Mahadevan S, Chavez G, Nguyen A, et al. An efficient light-driven P450 BM3 biocatalyst. J Am Chem Soc. 2013;135:14484-7 pubmed publisher

Huang W, Ellis J, Moody P, Raven E, Roberts G. Redox-linked domain movements in the catalytic cycle of cytochrome p450 reductase. Structure. 2013;21:1581-9 pubmed publisher

Lee C, Ding X, Riddick D. Downregulation of mouse hepatic CYP3A protein by 3-methylcholanthrene does not require cytochrome P450-dependent metabolism. Drug Metab Dispos. 2013;41:1782-6 pubmed publisher

Chandor Proust A, Bibby J, Régent Kloeckner M, Roux J, Guittard Crilat E, Poupardin R, et al. The central role of mosquito cytochrome P450 CYP6Zs in insecticide detoxification revealed by functional expression and structural modelling. Biochem J. 2013;455:75-85 pubmed publisher

Arendse L, Blundell T, Blackburn J. Combining in silico protein stability calculations with structure-function relationships to explore the effect of polymorphic variation on cytochrome P450 drug metabolism. Curr Drug Metab. 2013;14:745-63 pubmed

Nishida C, Everett S, Ortiz de Montellano P. Specificity determinants of CYP1B1 estradiol hydroxylation. Mol Pharmacol. 2013;84:451-8 pubmed publisher

Pengpai Z, Sheng H, Lehe M, Yinlin L, Zhihua J, Guixiang H. Improving the activity of cytochrome P450 BM-3 catalyzing indole hydroxylation by directed evolution. Appl Biochem Biotechnol. 2013;171:93-103 pubmed publisher

Jiang D, Tu R, Bai P, Wang Q. Directed evolution of cytochrome P450 for sterol epoxidation. Biotechnol Lett. 2013;35:1663-8 pubmed publisher

van de Waterbeemd B, Zomer G, Kaaijk P, Ruiterkamp N, Wijffels R, van den Dobbelsteen G, et al. Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis. PLoS ONE. 2013;8:e65157 pubmed publisher

Liu S, Yao Y, Lu S, ALDOUS K, Ding X, Mei C, et al. The role of renal proximal tubule P450 enzymes in chloroform-induced nephrotoxicity: utility of renal specific P450 reductase knockout mouse models. Toxicol Appl Pharmacol. 2013;272:230-7 pubmed publisher

Xie Z, Liu W, Xu Y, Chen S. [Optimization of tri-expression of human CYP3A4 with POR and cyt b5 in Sf 9 cells]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013;42:38-44 pubmed

Su J, Guise C, Wilson W. FSL-61 is a 6-nitroquinolone fluorogenic probe for one-electron reductases in hypoxic cells. Biochem J. 2013;452:79-86 pubmed publisher

Nambu S, Matsui T, Goulding C, Takahashi S, Ikeda Saito M. A new way to degrade heme: the Mycobacterium tuberculosis enzyme MhuD catalyzes heme degradation without generating CO. J Biol Chem. 2013;288:10101-9 pubmed publisher

Marchenko M, Ketsa O. [Generation of superoxide anion-radical in the liver monooxygenase system of preliminary radiation-exposed tumor-bearing rats]. Ukr Biokhim Zh (1999). 2012;84:101-8 pubmed

Stiborova M, Cechova T, Bořek Dohalská L, Moserova M, Frei E, Schmeiser H, et al. Activation and detoxification metabolism of urban air pollutants 2-nitrobenzanthrone and carcinogenic 3-nitrobenzanthrone by rat and mouse hepatic microsomes. Neuro Endocrinol Lett. 2012;33 Suppl 3:8-15 pubmed

Meints C, Simtchouk S, Wolthers K. Aromatic substitution of the FAD-shielding tryptophan reveals its differential role in regulating electron flux in methionine synthase reductase and cytochrome P450 reductase. FEBS J. 2013;280:1460-74 pubmed publisher

Haque M, Bayachou M, Fadlalla M, Durra D, Stuehr D. Charge-pairing interactions control the conformational setpoint and motions of the FMN domain in neuronal nitric oxide synthase. Biochem J. 2013;450:607-17 pubmed publisher

Sideri A, Goyal A, Di Nardo G, Tsotsou G, Gilardi G. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution. J Inorg Biochem. 2013;120:1-7 pubmed publisher

Lee C, Ding X, Riddick D. The role of cytochrome P450-dependent metabolism in the regulation of mouse hepatic growth hormone signaling components and target genes by 3-methylcholanthrene. Drug Metab Dispos. 2013;41:457-65 pubmed publisher

Zhang P, Jia K, Fang C, Zhou X, Ding X, Zhang Q. Dietary regulation of mouse intestinal P450 expression and drug metabolism. Drug Metab Dispos. 2013;41:529-35 pubmed publisher

Araki N, Tsuruoka S, Hasegawa G, Yanagihara H, Omasa T, Enosawa S, et al. Inhibition of CYP3A4 by 6',7'-dihydroxybergamottin in human CYP3A4 over-expressed hepG2 cells. J Pharm Pharmacol. 2012;64:1715-21 pubmed publisher

Schuckel J, Rylott E, Grogan G, Bruce N. A gene-fusion approach to enabling plant cytochromes p450 for biocatalysis. Chembiochem. 2012;13:2758-63 pubmed publisher

Miller W. P450 oxidoreductase deficiency: a disorder of steroidogenesis with multiple clinical manifestations. Sci Signal. 2012;5:pt11 pubmed publisher

Riddick D, Ding X, Wolf C, Porter T, Pandey A, Zhang Q, et al. NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology. Drug Metab Dispos. 2013;41:12-23 pubmed publisher

Shen Q, Chen Y, Wang T, Wu S, Lu X, Zhang L, et al. Overexpression of the cytochrome P450 monooxygenase (cyp71av1) and cytochrome P450 reductase (cpr) genes increased artemisinin content in Artemisia annua (Asteraceae). Genet Mol Res. 2012;11:3298-309 pubmed publisher

Hu L, Zhuo W, He Y, Zhou H, Fan L. Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy. Pharmacogenet Genomics. 2012;22:812-9 pubmed publisher

Kenaan C, Shea E, Lin H, Zhang H, Pratt Hyatt M, Hollenberg P. Interactions between CYP2E1 and CYP2B4: effects on affinity for NADPH-cytochrome P450 reductase and substrate metabolism. Drug Metab Dispos. 2013;41:101-10 pubmed publisher

Lin H, Kenaan C, Zhang H, Hollenberg P. Reaction of human cytochrome P450 3A4 with peroxynitrite: nitrotyrosine formation on the proximal side impairs its interaction with NADPH-cytochrome P450 reductase. Chem Res Toxicol. 2012;25:2642-53 pubmed publisher

Zhao Y, Vanhoutte P, Leung S. Endothelial nitric oxide synthase-independent release of nitric oxide in the aorta of the spontaneously hypertensive rat. J Pharmacol Exp Ther. 2013;344:15-22 pubmed publisher

Convery J, Smith C, Khara B, Scrutton N, Harrison P, Farrell T, et al. Controlling the formation of a monolayer of cytochrome P450 reductase onto Au surfaces. Phys Rev E Stat Nonlin Soft Matter Phys. 2012;86:011903 pubmed

Pottier M, Bozzolan F, Chertemps T, Jacquin Joly E, Lalouette L, Siaussat D, et al. Cytochrome P450s and cytochrome P450 reductase in the olfactory organ of the cotton leafworm Spodoptera littoralis. Insect Mol Biol. 2012;21:568-80 pubmed publisher

Iyanagi T, Xia C, KIM J. NADPH-cytochrome P450 oxidoreductase: prototypic member of the diflavin reductase family. Arch Biochem Biophys. 2012;528:72-89 pubmed publisher

Lee C, Riddick D. Aryl hydrocarbon receptor-dependence of dioxin's effects on constitutive mouse hepatic cytochromes P450 and growth hormone signaling components. Can J Physiol Pharmacol. 2012;90:1354-63 pubmed publisher

Dudka J, Burdan F, Korga A, Iwan M, Madej Czerwonka B, Cendrowska Pinkosz M, et al. Intensification of doxorubicin-related oxidative stress in the heart by hypothyroidism is not related to the expression of cytochrome P450 NADPH-reductase and inducible nitric oxide synthase, as well as activity of xanthine oxidase. Oxid Med Cell Longev. 2012;2012:139327 pubmed publisher

Geier M, Braun A, Emmerstorfer A, Pichler H, Glieder A. Production of human cytochrome P450 2D6 drug metabolites with recombinant microbes--a comparative study. Biotechnol J. 2012;7:1346-58 pubmed publisher

Vincent B, Morellet N, Fatemi F, Aigrain L, Truan G, Guittet E, et al. The closed and compact domain organization of the 70-kDa human cytochrome P450 reductase in its oxidized state as revealed by NMR. J Mol Biol. 2012;420:296-309 pubmed publisher

Fredenhagen A, Kittelmann M, Oberer L, Kuhn A, Kühnöl J, Délémonté T, et al. Biocatalytic synthesis and structure elucidation of cyclized metabolites of the deacetylase inhibitor panobinostat (LBH589). Drug Metab Dispos. 2012;40:1041-50 pubmed publisher

Pudney C, Khara B, Johannissen L, Scrutton N. Coupled motions direct electrons along human microsomal P450 Chains. PLoS Biol. 2011;9:e1001222 pubmed publisher

Penketh P, Baumann R, Shyam K, Williamson H, Ishiguro K, Zhu R, et al. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): a cytotoxic prodrug with two stable conformations differing in biological and physical properties. Chem Biol Drug Des. 2011;78:513-26 pubmed publisher

Masters B, Kamin H, Gibson Q, Williams C. STUDIES ON THE MECHANISM OF MICROSOMAL TRIPHOSPHOPYRIDINE NUCLEOTIDE-CYTOCHROME C REDUCTASE. J Biol Chem. 1965;240:921-31 pubmed

Williams C, Kamin H. Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J Biol Chem. 1962;237:587-95 pubmed

Gutierrez A, Grunau A, Paine M, Munro A, Wolf C, Roberts G, et al. Electron transfer in human cytochrome P450 reductase. Biochem Soc Trans. 2003;31:497-501 pubmed

Munro A, Noble M, Robledo L, Daff S, Chapman S. Determination of the redox properties of human NADPH-cytochrome P450 reductase. Biochemistry. 2001;40:1956-63 pubmed

Sevrioukova I, Peterson J. NADPH-P-450 reductase: structural and functional comparisons of the eukaryotic and prokaryotic isoforms. Biochimie. 1995;77:562-72 pubmed

Lu A, Junk K, Coon M. Resolution of the cytochrome P-450-containing omega-hydroxylation system of liver microsomes into three components. J Biol Chem. 1969;244:3714-21 pubmed

Masters B, Bilimoria M, Kamin H, Gibson Q. The mechanism of 1- and 2-electron transfers catalyzed by reduced triphosphopyridine nucleotide-cytochrome c reductase. J Biol Chem. 1965;240:4081-8 pubmed